Products
Built multiple sets of modular, multi-functional intelligent drug automati₽c synthesis platform
OnePlatform version 3.1
Keywords: synthetic equipment disposable consumables
Classification:
Synthesis Equipment
Hotline:
OnePlatform version 3.1
Graphic Details
OnePlatform 3.1, as a simple, stable and repeatable standa®rdized drug synthesis system, is suitable for the dγevelopment of complex radiochemical labeling processes. It has t♠he characteristics of high automation, small volume, and strong stability. At the same time, it realizes the automation of the entire process of drug synthesis, including nuclide l₽eaching, quality control, separation and purification, filtration and s terilization.
OnePlatform3.1 is mainly used for nuclide labeling such as 18F, 11C, 68Ga, 64Cu, and includes the following features:
● Realize the synthesis of small molecule, peptide, protein/antibody labeling functi'ons;
● High design flexibility and strong exploitability;
● Combination modular design, with optional functional modules to achieve multiple functions on the basis of the host;
The company has developed new synthesis processes fo®r various new nuclide labeled positron emission tomography tracers (such as 18÷F Safranamide, 18F FHBG, 18F MK9470, etc.), which have appli cation value in the mechanism research and diagnosis of major diseases su£ch as tumors, cardiovascular and cerebrovascular diseases, and neurodegeneration≠. The company's core products include the design and manufacturing of advanced automa≠tic synthesis systems for radioactive drugs, as well as the de↓sign, synthesis, and production of PET tracers.
Previous Page
OnePlatform3.1 Advanced Edition
Next Page
Related Products
Consulting